强心康对LVEF降低性心衰患者BNP、RDW水平的影响

蔡少杭; 吴怡萍; 陈晖; 刘雪娜

强心康对LVEF降低性心衰患者BNP、RDW水平的影响

漳州市中医院心内科，福建漳州 363000

计量
- 文章访问数: 993
- HTML全文浏览量: 4
- PDF下载量: 1297
- 被引次数: 0
出版历程
- 收稿日期: 2014-12-11
- 修回日期: 2015-01-17
- 刊出日期: 2015-03-10

Effect of QiangXinKang on BNP and RDW Level of patients with Heart Failure with Reduced LVEF

摘要

摘要: 目的通过观察强心康对左室射血分数（LVEF）降低性心力衰竭(简称心衰)患者血清脑钠肽（BNP）及红细胞体积分布宽度（RDW）浓度的影响，探讨强心康在慢性LVEF降低性心衰治疗中可能的作用靶点。方法将符合LVEF降低性心衰诊断标准的患者198例，随机分为试验组102例，对照组96例。2组均依据《中国心力衰竭诊断和治疗指南2007》给予慢性心衰常规治疗；试验组在常规治疗基础上加用强心康。4周后比较2组治疗前后BNP、RDW水平及LVEF变化情况。结果随着LVEF改善，治疗后2组患者血清BNP浓度及RDW水平均较治疗前下降，而以治疗组降低明显，2组间具有显著性差异（P＜0.05）。结论强心康可显著降低LVEF降低性心衰患者血清BNP及RDW水平，改善LVEF降低性心衰患者的心功能。
- 强心康 /
- LVEF降低性心衰 /
- B型利钠肽 /
- 红细胞体积分布宽度
Abstract: OBJECTIVE This paper is to discuss possible targets in the treatment of heart failure with reduced left ventricular ejection fraction (HFREF) with QiangXinKang by observing the effect of QiangXinKang on the brain natriuretic peptide (BNP) and red blood cell volume distribution width (RDW) of patients with HFREF. METHODS 198 patients meeting the selecting criteria of HFREF were randomly divided into the experimental group with 102 cases and the control group with 96 cases. Both groups received routine treatments conforming to Guideline for the Diagnosis and Treatment for Heart Failure (2007 Edition) and the experimental group took QiangXinKang additionally. After 4-week treatment， changes of BNP， RDW level and LVEF were compared between the two groups before and after treatment. RESULTS As LVEF was improved after treatment， BNP concentration and RDW level of patients in both groups were significantly reduced， while those of the experimental group decreased more significantly， which showed a significant difference between the two groups (P<0.05). CONCLUSION QiangXinKang may significantly reduce the BNP and RDW level and improve the heart function of patients with HFREF.

HTML全文

参考文献(10)

[1]	中华医学会心血管病学分会，中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志，2014，42(2)：98-122.
[2]	Cardiology of Chinese Medical Association， editorial board of Chinese Journal of Cardiovascular Disease. Guideline for the Diagnosis and Treatment for Heart Failure 2014[J].Chin J Cardiol，2014，42(2):98-122.
[3]	王燕，张洋，丛祥凤，等．红细胞分布宽度和高敏C反应蛋白对老年心衰患者住院死亡的预测价值[J]．中国老年学杂志，2012，6（8）：1562-1565．
[4]	Wang Y， Zhang Y， Cong XF， et al. Predictive value of red blood cell distribution width and high sensitive C reactive protein on hospital death of senior patients with heart failure[J]. Chin J Gerontol， 2012， 6(8): 1562-1565.
[5]	〖JP3〗中华医学会心血管病学分会，中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志，2007，35(12):1076-1095.〖JP〗
[6]	〖JP3〗Cardiology of Chinese Medical Association， editorial board of Chinese Journal of Cardiovascular Disease. Guideline for the diagnosis and treatment for heart failure[J].Chin J Cardiol，2007，35(12):1076-1095.〖JP〗
[7]	Harvey RM， Ferrer MI，Turino GM.Philosophy of the New York Heart Association regarding assessment of cardiovascularfunction[J].Circulation(Baltimore)，1982，66(1):249.
[8]	Felker GM， Allen LA， Pocock SJ， et al. Red cell distribution width as a novel prognostic marker in heart failure data from the(HARM program and the duke databank)[J]. J Am Coll Cardiol， 2007， 50(1): 40-47.
[9]	蔡少杭，陈晖，刘雪娜，等．强心康治疗慢性充血性心力衰竭108例临床分析[J]．中国中医急症，2008， 17（9）：1187-1188．
[10]	Cai SH， Chen H， Liu XN，et al. Clinical study on the treatment of 108 chronic congestive heart failure cases with QiangXinTong[J]. J Emerg Tradit Chin Med， 2008， 17(9): 1187-1188.